Federica Biello
Ospedale Maggiore(IT)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, COVID-19 and healthcare impacts, Cancer Genomics and Diagnostics, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients(2019)193 cited
- → Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer(2020)182 cited
- → Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study(2021)134 cited
- → Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer(2020)109 cited
- → Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients(2018)88 cited
- → Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study(2022)80 cited
- → Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System(2014)73 cited
- → Time-Dependent COVID-19 Mortality in Patients With Cancer(2021)71 cited
- → Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe(2020)65 cited
- → Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab(2019)54 cited